NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SPARK Neuro

SPARK Neuro

Private
New York City, New YorkHealthcare & Life Scienceshttps://sparkneuro.com/

Last Round

Series A

Aug 8, 2018

Est. Valuation

$53.5M

Total Funding Raised

$16M

Company Overview

SPARK Neuro is a health technology company that develops a neuroscience diagnostic platform intended to analyze brain activity for the detection and monitoring of neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Devices, ML Platforms, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

dementia diagnosisEEG analysis softwarecognitive impairmentSoftware as a Medical DeviceSaMDmedical AIAI diagnosticsAlzheimer's diseasebrain scan AIEEG biomarker discoveryneurotechnologyFDA cleareddigital biomarkersprimary care toolsneurology tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SPARK Neuro Comparables

Compare SPARK Neuro with similar companies based on industry and business-model similarity.

SPARK Neuro comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Linus Health
85%
Cognision
84%
Darmiyan
81%

SPARK Neuro Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 8, 2018

Key People

Founding team and executive leadership

Spencer Gerrol

Chief Executive Officer

Executive Team

Marinela Gombosev

President, COO

Executive Team

SPARK Neuro Investors

Notable investors and investment history

SPARK Neuro investors
InvestorRounds
NIH RADxGrant
Thiel CapitalSeries A
The Tornante CompanySeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 27, 2026

    Monthly visitors increased 127% MoM, reaching 3.2K.

  • Sep 12, 2023

    Grew 17% QoQ, from 23 to 27 employees.

SPARK Neuro Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SPARK Neuro Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SPARK Neuro's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range17
Year Founded2017
Last FundingAug 8, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.